Interleukin 10 Inhibits Cytokine Production of Human AML Cells
Overview
Affiliations
Background: Unlike normal hematopoietic cells leukemic blasts from patients with AML constitutively express cytokines like IL1, GM-CSF and TNF alpha and it has been suggested that these cytokines may regulate growth and differentiation of the malignant cells. IL10 inhibits cytokine production of activated macrophages and T-helper 1 cells. We analysed whether IL10 can also suppress cytokine production and may inhibit growth of AML cells.
Materials And Methods: AML blasts of 18 patients were purified by immunomagnetic separation and cultured in serum-free medium in the presence of cytokines. The production of cytokines was analysed by ELISA, DNA synthesis by 3H-thymidine incorporation and mRNA expression of cytokine genes by semiquantitative RT-PCR.
Results: Our results confirm previous results that AML blasts produce a variety of cytokines such as GM-CSF, IL1 alpha, IL1 beta, IL6 and TNF alpha. AML cells were induced to proliferation by G-CSF, GM-CSF, IL3, IL1 beta and SCF to a different extent. In contrast, IL10 significantly inhibited the cytokine production at the mRNA and protein level and spontaneous thymidine uptake in a dose-dependent way. This inhibition could be abrogated by IL10 specific antibodies.
Conclusion: These observations suggest an inhibitory effect of IL10 on the proliferation of cultured AML blasts most likely through suppression of endogenous cytokines.
Zhu Z, Zhao Y, Li P J Cancer. 2025; 16(4):1228-1242.
PMID: 39895788 PMC: 11786050. DOI: 10.7150/jca.108041.
Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia.
Naji N, Sathish M, Karantanos T Cancers (Basel). 2024; 16(23).
PMID: 39682161 PMC: 11640130. DOI: 10.3390/cancers16233974.
Luo C, Zhang W, Zhu J, Qiu T, Fang Q Heliyon. 2024; 10(12):e33194.
PMID: 39022041 PMC: 11252755. DOI: 10.1016/j.heliyon.2024.e33194.
Mougeot J, Beckman M, Alexander A, Hovan A, Hasseus B, Legert K Support Care Cancer. 2024; 32(4):220.
PMID: 38467943 DOI: 10.1007/s00520-024-08408-3.
Li B, Can C, Liu W, Guo X, Wu H, Wei Y J Cancer Res Clin Oncol. 2023; 149(19):17307-17318.
PMID: 37819582 DOI: 10.1007/s00432-023-05440-4.